...
首页> 外文期刊>Clinical epigenetics. >Loss of nuclear localization of TET2 in colorectal cancer
【24h】

Loss of nuclear localization of TET2 in colorectal cancer

机译:TET2核定位在大肠癌中的丧失。

获取原文
           

摘要

5-Hydroxymethylcytosine (5hmC) is lost in multiple human cancers, including colorectal cancer (CRC). Decreased ten-eleven translocation 1 (TET1) messenger RNA (mRNA), but not other two TET family members, has been observed in the colorectal cancer and is crucial for colorectal cancer initiation. Here, we show that nuclear localization of TET2 was lost in a significant portion of CRC tissues, in association with metastasis. In CRC cells, nuclear expression of TET2 were absent but not TET3. Nuclear export inhibitor can increase the 5hmC level in CRC cells, probably through regulating TET2. Our results indicate a new mechanism of TET2 dysregulation in colorectal cancer.
机译:5-羟甲基胞嘧啶(5hmC)在多种人类癌症(包括结直肠癌(CRC))中丢失。在结直肠癌中观察到减少的11-11易位1(TET1)信使RNA(mRNA),但没有其他2个TET家族成员,这对于结直肠癌的发生至关重要。在这里,我们显示,TET2的核定位在与转移相关的CRC组织的显着部分中丢失了。在CRC细胞中,没有TET2的核表达,但没有TET3。核输出抑制剂可能通过调节TET2来增加CRC细胞中5hmC的水平。我们的结果表明大肠癌中TET2失调的新机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号